New York § 60.49 Possession of opioid antagonists; receipt into evidence

New York Statutes

§ 60.49 — Possession of opioid antagonists; receipt into evidence

New York § 60.49

JurisdictionNew York

Law CPLCriminal Procedure

Title DRules of Evidence, Standards of Proof and Related Matters

Part 1General Provisions

Art. 60Rules of Evidence and Related Matters

This text of New York § 60.49 (Possession of opioid antagonists; receipt into evidence) is published on Counsel Stack Legal Research, covering New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

N.Y. Criminal Procedure § 60.49 (2026).

Text

§ 60.49 Possession of opioid antagonists; receipt into evidence.\n  1. Evidence that a person was in possession of an opioid antagonist\nmay not be admitted at any trial, hearing or other proceeding in a\nprosecution for any offense under sections 220.03, 220.06, 220.09,\n220.16, 220.18, or 220.21 of the penal law for the purpose of\nestablishing probable cause for an arrest or proving any person's\ncommission of such offense.\n  2. For the purposes of this section, opioid antagonist is defined as a\ndrug approved by the Food and Drug Administration that, when\nadministered, negates or neutralizes in whole or in part the\npharmacological effects of an opioid in the body and shall be limited to\nnaloxone and other medications approved by the department of health for\nsuch purpose.\n

Free access — add to your briefcase to read the full text and ask questions with AI

§ 60.49 Possession of opioid antagonists; receipt into evidence.\n 1. Evidence that a person was in possession of an opioid antagonist\nmay not be admitted at any trial, hearing or other proceeding in a\nprosecution for any offense under sections 220.03, 220.06, 220.09,\n220.16, 220.18, or 220.21 of the penal law for the purpose of\nestablishing probable cause for an arrest or proving any person's\ncommission of such offense.\n 2. For the purposes of this section, opioid antagonist is defined as a\ndrug approved by the Food and Drug Administration that, when\nadministered, negates or neutralizes in whole or in part the\npharmacological effects of an opioid in the body and shall be limited to\nnaloxone and other medications approved by the department of health for\nsuch purpose.\n